Peking University Cancer Hospital & Institute

This study is testing a personalized approach to treatment after surgery for early-stage lung cancer. It uses a sensitive blood test to check for tiny amounts of leftover cancer cells. Patients with no detectable cancer cells in two tests may be able to skip standard chemotherapy…

This study is testing whether giving a combination of an immunotherapy drug (camrelizumab) and chemotherapy before surgery can shrink tumors enough to preserve the esophagus in patients with a type of esophageal cancer. The goal is to see if this approach can control the cancer e…

This study is testing whether adding a new immunotherapy drug (adebrelimab) to standard chemotherapy helps people with a type of esophageal cancer that can be removed by surgery. The goal is to shrink the tumor before the operation and then continue the immunotherapy afterward to…

This study is observing how well an existing drug called Trop-2 ADC (sacituzumab govitecan) works for breast cancer patients whose cancer has spread to the brain. Researchers will collect data from about 100 patients already receiving this drug in their normal care at multiple ho…

This study is testing a combination of targeted drugs and chemotherapy for people with a rare, aggressive type of stomach cancer. The goal is to shrink the tumor before surgery and prevent it from coming back after. About 30 participants will receive the drug combination before a…

This early-stage study is testing the safety and initial effectiveness of a new combination treatment for advanced small cell lung cancer. It combines a radioactive drug that targets specific tumor markers with an immunotherapy drug, given as a maintenance therapy after initial c…

This study is testing a treatment plan for a rare and aggressive type of stomach cancer. It combines chemotherapy and immunotherapy drugs given both before and after surgery. The goal is to see if this approach can shrink or eliminate the tumor before surgery and prevent it from …

This study is testing a new imaging agent for PET/CT scans to see if it can better detect and locate bladder cancer, especially when it has come back or spread. The agent is designed to stick to a specific protein (nectin-4) that is often found on bladder cancer cells. Researcher…

This study is testing a new type of PET scan designed to detect a specific protein called CLDN18.2 on cancer cells. The goal is to see if this scan can accurately find tumors that have this protein, which could help doctors identify patients who might benefit from new targeted th…

This study is testing whether a traditional Chinese herbal formula called Modified Bufei Decoction can help reduce common symptoms like cough, fatigue, and shortness of breath in elderly patients recovering from lung cancer surgery. Researchers will compare the herbal formula aga…